Home / Health / Cancer Care Disrupted: Patients Face New Insurance Woes
Cancer Care Disrupted: Patients Face New Insurance Woes
5 Sep
Summary
- Mass General Brigham Health Plan removed Dana-Farber from its Medicare Advantage network.
- Hundreds of patients face uncertainty about their cancer treatment coverage.
- The change affects patients starting October 1st, with a 90-day transition period.
Hundreds of patients are facing difficult choices regarding their cancer care as the Mass General Brigham Health Plan removes Dana-Farber Cancer Institute from its Medicare Advantage network. This change, effective October 1st, will impact approximately 1,000 patients who have relied on Dana-Farber for treatment.
Eldon Clingan, an 88-year-old with a long-standing prostate cancer diagnosis, expressed significant anxiety over potentially losing coverage for his established treatment and medication. MGB Health Plan stated the decision is due to a challenging national environment for Medicare Advantage plans, asserting it's unrelated to Dana-Farber's decision to end its partnership with the MGB hospital system in 2028.
Patients have a 90-day transition period to adapt. However, after January 1st, 2027, those wishing to continue their care at Dana-Farber will require a new insurance plan. Exceptions for extended coverage may apply for patients in clinical trials or undergoing specific treatments like radiation or chemotherapy.
